Form 4 for BBNX Beta Bionics, Inc.
Accepted 2025-10-03 00:00:00 ET · period of report 2025-10-01 · accession 0002048588-25-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-10-03 | 2025-10-01 | BBNX | Feider Stephen | CFO | S - Sale+OE | $20.76 | -15.0K | 44.0K | -25% | -$311.8K |
| D | 2025-10-03 | 2025-10-01 | BBNX | Feider Stephen | CFO | M - OptEx | $5.10 | +15.0K | 59.1K | +34% | +$76.6K |
| D | 2025-10-03 | 2025-10-01 | BBNX | Feider Stephen | CFO | M - OptEx | $0.00 | -15.0K | 74.7K | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-01 | S | D | 14,918 | $20.76 | 44,141 | D | — | — | (F2) The weighted average sale price for the transaction reported was $20.76 and the range of prices were between $20.03 and $21.03. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 2 | Common | Common Stock | 2025-10-01 | S | D | 100 | $21.08 | 44,041 | D | — | — | |
| 3 | Common | Common Stock | 2025-10-01 | M | A | 15,018 | $5.10 | 59,059 | D | — | — | |
| 4 | Derivative | Employee Stock Option (right to buy) | 2025-10-01 | M | D | 15,018 | $0.00 | 74,677 | D | $5.10 · — to 2033-09-13 | 15,018 Common Stock | (F3) The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023. |